AI Tokens
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Analysis of Income Taxes

Microsoft Excel

Income Tax Expense (Benefit)

Abiomed Inc., income tax expense (benefit), continuing operations

US$ in thousands

Microsoft Excel
12 months ended: Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Federal 25,893 8,624 — — 752 7,313
State 9,184 12,379 6,563 564 1,491 5,045
Foreign 16,565 12,312 14,300 11,525 3,400 1,066
Current tax expense 51,642 33,315 20,863 12,089 5,643 13,424
Federal 5,376 30,413 33,239 (7,153) 38,848 23,008
State (1,720) (2,382) 1,584 (1,503) (1,014) (349)
Foreign (1,243) 1,349 (1,870) 911 4,790 3,144
Deferred tax expense (benefit) 2,413 29,380 32,953 (7,745) 42,624 25,803
Income tax provision 54,055 62,695 53,816 4,344 48,267 39,227

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).


The analysis of income tax components from 2017 to 2022 reveals a general upward trajectory in tax liabilities, characterized by steady growth in current tax obligations and significant volatility within deferred tax accounts.

Current Tax Expense Trends
Current tax expenses exhibited a consistent growth pattern following a decline in 2018. From a low of 5.6 million US dollars in 2018, expenses rose steadily to 51.6 million US dollars by March 31, 2022. This sustained increase suggests a growth in taxable income and operational profitability over the analyzed period.
Deferred Tax Volatility
Deferred tax expenses demonstrated substantial fluctuations, indicating varying timing differences between accounting and tax reporting. A peak expense of 42.6 million US dollars in 2018 was followed by a tax benefit of 7.7 million US dollars in 2019. Following this, expenses surged again in 2020 and 2021 before declining sharply to 2.4 million US dollars in 2022.
Overall Income Tax Provision
The total income tax provision fluctuated between 2017 and 2022, reaching a peak of 62.7 million US dollars in 2021. A significant outlier occurred on March 31, 2019, when the provision dropped to 4.3 million US dollars, primarily driven by the deferred tax benefit recognized in that period. A rapid recovery followed in 2020, with the provision returning to 53.8 million US dollars.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Effective Income Tax Rate (EITR)

Abiomed Inc., effective income tax rate (EITR) reconciliation

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Statutory income tax rate 21.00% 21.00% 21.00% 21.00% 31.50% 35.00%
Credits -11.30% -6.00% -10.80% -1.50% -4.90% -3.30%
Non-deductible acquired IPR&D 10.50% 0.00% 0.00% 0.00% 0.00% 0.00%
Rate differential on foreign operations 6.50% 4.10% 3.20% 0.20% 0.00% 0.10%
Excess tax benefits from stock-based awards -4.80% -3.30% -5.20% -24.10% -17.20% 0.20%
State taxes, net 4.30% 3.20% 3.10% 0.10% 2.00% 3.80%
Non-deductible officers’ compensation 2.00% 1.40% 1.20% 0.00% 0.00% 0.00%
Permanent differences 0.90% 1.00% 3.80% 1.80% 2.40% 3.30%
Change in valuation allowance 0.30% 0.30% 5.30% -0.40% 0.50% 0.20%
Foreign taxes 0.00% 0.00% 0.00% 4.10% 2.20% 2.00%
Other -1.00% 0.10% -0.60% 0.40% 0.60% 1.70%
Effective income tax rate, before effect of the Tax Reform Act on net deferred tax assets 28.40% 21.80% 21.00% 1.60% 17.10% 43.00%
Effect of the Tax Reform Act on net deferred tax assets 0.00% 0.00% 0.00% 0.00% 13.00% 0.00%
Effective income tax rate 28.40% 21.80% 21.00% 1.60% 30.10% 43.00%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).


The Effective Income Tax Rate (EITR) exhibited significant volatility between 2017 and 2022, fluctuating from a peak of 43.0% to a low of 1.6%. While the statutory income tax rate underwent a structural decline from 35.0% in 2017 to a stabilized 21.0% from 2019 onward, the actual tax burden was heavily influenced by various permanent and temporary differences.

Statutory Rate and Regulatory Transitions
A downward shift in the statutory tax rate is observed, moving from 35.0% in 2017 to 21.0% by 2019. The transition period in 2018 was marked by a 13.0% impact from the Tax Reform Act on net deferred tax assets, which adjusted the EITR to 30.1%.
Primary Drivers of EITR Reduction
The most substantial reduction in the EITR occurred in 2019, where the rate dropped to 1.6%. This was primarily driven by excess tax benefits from stock-based awards, which provided a 24.1% reduction in that year. Additionally, tax credits consistently acted as a downward pressure on the rate, reaching their most significant impact in 2022 at -11.3%.
Factors Contributing to Rate Increases
Following the 2019 low, the EITR trended upward to 28.4% by 2022. This increase is linked to a growing rate differential on foreign operations, which climbed steadily from 0.1% in 2017 to 6.5% in 2022. A sharp increase in the 2022 EITR is further attributed to the introduction of non-deductible acquired in-process research and development (IPR&D), which added 10.5% to the tax rate.
Secondary Tax Adjustments
State taxes remained a consistent additive factor, peaking at 4.3% in 2022. Non-deductible officers' compensation also became a recurring upward adjustment starting in 2020, contributing between 1.2% and 2.0% to the EITR over the subsequent three years.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Components of Deferred Tax Assets and Liabilities

Abiomed Inc., components of deferred tax assets and liabilities

US$ in thousands

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Net operating loss and tax credit carryforwards 29,802 27,893 50,604 62,835 48,724 8,814
Stock-based compensation 14,608 13,790 13,607 15,488 13,271 16,560
Nondeductible reserves and accruals 15,441 12,097 9,570 9,739 8,290 10,303
Foreign net operating loss carryforwards 9,107 6,856 6,778 7,360 9,598 13,634
Deferred revenue 5,830 5,522 4,404 3,677 3,770 4,308
Other, net 312 363 1,063 613 1,648 3,443
Deferred tax assets, before valuation allowance 75,100 66,521 86,026 99,712 85,301 57,062
Valuation allowance (19,405) (15,667) (15,170) (1,302) (1,652) (2,468)
Deferred tax assets 55,695 50,854 70,856 98,410 83,649 54,594
Goodwill (7,829) (7,897) (7,843) (7,136) (6,787) (9,444)
In-process research and development (12,063) (12,496) (4,564) (4,593) (5,045) (4,374)
Depreciation (14,197) (11,747) (9,211) (2,175) (1,011) —
Basis differences on other investments (11,442) (7,766) (6,124) (7,146) — —
Domestic deferred tax liability on foreign net operating loss carryforwards (393) (415) (584) (680) (963) (6,836)
Deferred tax liabilities (45,924) (40,321) (28,326) (21,730) (13,806) (20,654)
Net deferred tax assets (liabilities) 9,771 10,533 42,530 76,680 69,843 33,940

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).


The net deferred tax position experienced significant volatility between March 31, 2017, and March 31, 2022, characterized by an initial expansion followed by a marked contraction. Net deferred tax assets reached a peak of $76.68 million in 2019 before declining to $9.77 million by March 31, 2022.

Deferred Tax Asset Dynamics
The primary driver of deferred tax assets was the net operating loss and tax credit carryforwards, which rose from $8.81 million in 2017 to a peak of $62.84 million in 2019, before retreating to $29.80 million by 2022. A critical shift occurred in the valuation allowance, which remained low until March 2020, when it increased abruptly to $15.17 million and further expanded to $19.41 million by 2022, indicating a more conservative assessment of the realizability of these assets.
Deferred Tax Liability Growth
Deferred tax liabilities showed a steady upward trajectory, increasing from $20.65 million in 2017 to $45.92 million in 2022. This growth was largely propelled by liabilities associated with depreciation, which climbed from zero in 2017 to $14.20 million in 2022. Furthermore, liabilities for in-process research and development saw a significant increase in 2021, jumping to $12.50 million from a historical average of approximately $4.60 million.
Net Impact and Asset Realization
The decline in the net deferred tax asset position from 2019 to 2022 resulted from the convergence of three factors: the reduction in gross net operating loss carryforwards, the substantial increase in the valuation allowance, and the growth of deferred tax liabilities related to depreciation and investments. While nondeductible reserves and accruals trended upward, reaching $15.44 million in 2022, this was insufficient to offset the broader decline in the net tax asset balance.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Deferred Tax Assets and Liabilities, Classification

Abiomed Inc., deferred tax assets and liabilities, classification

US$ in thousands

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Deferred tax assets 10,552 11,380 43,336 77,502 70,746 34,723
Deferred tax liabilities 781 847 806 822 903 783

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).


Analysis of the deferred tax position reveals a significant divergence between the volatility of deferred tax assets and the stability of deferred tax liabilities over the six-year period ending March 31, 2022.

Deferred Tax Asset Trajectory
Deferred tax assets experienced a period of rapid expansion between 2017 and 2019, rising from $34.7 million to a peak of $77.5 million. This upward trend was followed by a substantial and consistent contraction, with assets decreasing to $43.3 million in 2020 and further declining to $10.6 million by March 31, 2022.
Deferred Tax Liability Stability
Deferred tax liabilities remained relatively static throughout the reporting period. Values fluctuated within a narrow range, peaking at $903 thousand in 2018 and reaching a low of $781 thousand in 2022, indicating that the temporary differences giving rise to these liabilities remained constant.
Net Deferred Tax Position
A net deferred tax asset position was maintained across all six years. Because the deferred tax liabilities were immaterial relative to the assets, the net position mirrored the volatility of the assets, resulting in a marked reduction of the net deferred tax benefit recognized on the balance sheet by the end of the period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjustments to Financial Statements: Removal of Deferred Taxes

Abiomed Inc., Financial Data: Reported vs. Adjusted

Abiomed Inc., adjustments to financial statements

US$ in thousands

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Adjustment to Total Assets
Total assets (as reported) 1,673,393 1,494,359 1,216,462 1,054,346 786,375 550,414
Less: Noncurrent deferred tax assets, net 10,552 11,380 43,336 77,502 70,746 34,723
Total assets (adjusted) 1,662,841 1,482,979 1,173,126 976,844 715,629 515,691
Adjustment to Total Liabilities
Total liabilities (as reported) 170,067 164,684 150,996 117,456 96,851 98,343
Less: Noncurrent deferred tax liabilities, net 781 847 806 822 903 783
Total liabilities (adjusted) 169,286 163,837 150,190 116,634 95,948 97,560
Adjustment to Stockholders’ Equity
Stockholders’ equity (as reported) 1,503,326 1,329,675 1,065,466 936,890 689,524 452,071
Less: Net deferred tax assets (liabilities) 9,771 10,533 42,530 76,680 69,843 33,940
Stockholders’ equity (adjusted) 1,493,555 1,319,142 1,022,936 860,210 619,681 418,131
Adjustment to Net Income
Net income (as reported) 136,505 225,525 203,009 259,016 112,170 52,116
Add: Deferred income tax expense (benefit) 2,413 29,380 32,953 (7,745) 42,624 25,803
Net income (adjusted) 138,918 254,905 235,962 251,271 154,794 77,919

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).


An analysis of the financial position and performance from 2017 to 2022 reveals a consistent expansion of the balance sheet, alongside a systematic variance between reported and adjusted figures resulting from the removal of deferred taxes.

Asset and Liability Adjustments
Total assets exhibited steady growth, increasing from 550,414 thousand US$ in 2017 to 1,673,393 thousand US$ in 2022. Throughout this period, adjusted total assets remained consistently lower than reported assets, indicating the presence of significant deferred tax assets. The absolute difference between reported and adjusted assets peaked in 2019 at 77,502 thousand US$. Similarly, adjusted total liabilities were consistently lower than reported liabilities, though the variance was less pronounced than that seen in assets, suggesting that deferred tax assets outweighed deferred tax liabilities in the overall adjustment process.
Impact on Stockholders’ Equity
Stockholders' equity followed an upward trajectory, growing from 452,071 thousand US$ in 2017 to 1,503,326 thousand US$ in 2022. The removal of deferred taxes resulted in a reduction of equity across all observed years. In 2017, the adjusted equity was approximately 6.8% lower than reported equity; however, by 2022, this gap narrowed to approximately 0.6%, indicating that the relative impact of deferred tax items on the total equity base diminished as the company grew.
Net Income Normalization
Reported net income showed significant volatility, peaking in 2019 at 259,016 thousand US$ before declining to 136,505 thousand US$ by 2022. In most years, adjusted net income was higher than reported net income, most notably in 2017, 2018, 2020, and 2021. This pattern indicates that deferred tax expenses typically reduced reported profitability. A divergence is observed in 2019, where adjusted net income was slightly lower than reported net income, and in 2022, where the two figures converged almost entirely, suggesting a shift in the tax profile or the realization of deferred tax items.

Overall, the removal of deferred taxes provides a view of the financial structure and earnings that is less influenced by accounting-based tax timing differences. The convergence of reported and adjusted figures in the later years suggests a stabilization of the tax position relative to the overall scale of the balance sheet.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)

Abiomed Inc., Financial Ratios: Reported vs. Adjusted

Abiomed Inc., adjusted financial ratios

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Net Profit Margin
Reported net profit margin 13.23% 26.61% 24.14% 33.66% 18.89% 11.70%
Adjusted net profit margin 13.46% 30.08% 28.06% 32.66% 26.07% 17.50%
Total Asset Turnover
Reported total asset turnover 0.62 0.57 0.69 0.73 0.76 0.81
Adjusted total asset turnover 0.62 0.57 0.72 0.79 0.83 0.86
Financial Leverage
Reported financial leverage 1.11 1.12 1.14 1.13 1.14 1.22
Adjusted financial leverage 1.11 1.12 1.15 1.14 1.15 1.23
Return on Equity (ROE)
Reported ROE 9.08% 16.96% 19.05% 27.65% 16.27% 11.53%
Adjusted ROE 9.30% 19.32% 23.07% 29.21% 24.98% 18.64%
Return on Assets (ROA)
Reported ROA 8.16% 15.09% 16.69% 24.57% 14.26% 9.47%
Adjusted ROA 8.35% 17.19% 20.11% 25.72% 21.63% 15.11%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).


The removal of deferred taxes results in a consistent upward adjustment of profitability and efficiency ratios throughout the majority of the analyzed period, with the most pronounced variances occurring between 2017 and 2021. The disparity between reported and adjusted figures indicates that deferred tax accounting had a significant suppressive effect on the company's reported performance metrics in the early years.

Profitability Analysis
Net profit margins show a substantial increase when adjusted for deferred taxes, particularly from 2017 to 2021. While both reported and adjusted margins peaked in 2019, the adjusted figures provided a more optimistic view of profitability during the initial growth phase. This trend is mirrored in the Return on Equity (ROE) and Return on Assets (ROA). In 2017, the adjusted ROE of 18.64% significantly outperformed the reported 11.53%, and the adjusted ROA of 15.11% exceeded the reported 9.47%, demonstrating that deferred tax liabilities likely weighed heavily on reported returns.
Asset Efficiency and Leverage
A gradual decline in total asset turnover is observed from 2017 to 2022. The adjusted total asset turnover remains higher than the reported ratio until 2021, suggesting that the removal of deferred tax impacts improves the perceived efficiency of asset utilization. In contrast, financial leverage remains relatively stable across the period, with minimal variance between reported and adjusted ratios, trending slightly downward from 1.23 (adjusted) in 2017 to 1.11 in 2022.
Convergence of Metrics
A distinct convergence between reported and adjusted ratios occurs by March 31, 2022. By this date, the variance across net profit margin, ROE, and ROA becomes negligible. This suggests that the influence of deferred taxes on the financial position diminished significantly toward the end of the analyzed timeframe, leading to a near-alignment of reported and adjusted financial performance.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Net Profit Margin

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income 136,505 225,525 203,009 259,016 112,170 52,116
Revenue 1,031,753 847,522 840,883 769,432 593,749 445,304
Profitability Ratio
Net profit margin1 13.23% 26.61% 24.14% 33.66% 18.89% 11.70%
Adjusted for Deferred Taxes
Selected Financial Data (US$ in thousands)
Adjusted net income 138,918 254,905 235,962 251,271 154,794 77,919
Revenue 1,031,753 847,522 840,883 769,432 593,749 445,304
Profitability Ratio
Adjusted net profit margin2 13.46% 30.08% 28.06% 32.66% 26.07% 17.50%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 Net profit margin = 100 × Net income ÷ Revenue
= 100 × 136,505 ÷ 1,031,753 = 13.23%

2 Adjusted net profit margin = 100 × Adjusted net income ÷ Revenue
= 100 × 138,918 ÷ 1,031,753 = 13.46%


The financial trajectory from 2017 to 2022 exhibits a period of significant expansion followed by a sharp contraction in profitability. Both reported and adjusted metrics indicate a peak in performance around 2019, with a notable convergence of reported and adjusted figures by the end of the observed period.

Net Income Performance
Reported net income grew rapidly from US$ 52,116 thousand in 2017 to a peak of US$ 259,016 thousand in 2019. Adjusted net income followed a similar upward trajectory and remained consistently higher than reported figures between 2017 and 2021, suggesting the presence of non-recurring expenses or specific tax-related adjustments that negatively impacted reported earnings. A significant decrease is observed in 2022, where reported net income fell to US$ 136,505 thousand.
Net Profit Margin Trajectory
The reported net profit margin experienced an aggressive increase from 11.70% in 2017 to a high of 33.66% in 2019. Following this peak, the margin fluctuated, remaining relatively stable between 2020 and 2021 before dropping sharply to 13.23% in 2022. The adjusted net profit margin mirrored this pattern, peaking at 32.66% in 2019 and declining to 13.46% by 2022.
Analysis of Reported versus Adjusted Margins
A persistent variance existed between reported and adjusted profit margins from 2017 to 2021, with the adjusted margin typically reflecting higher profitability. For example, in 2021, the adjusted margin of 30.08% exceeded the reported margin of 26.61%. However, by 2022, this gap narrowed substantially to 0.23 percentage points, indicating that the factors necessitating adjustments had a minimal impact on the net profit margin in the final year of the period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Total Asset Turnover

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Revenue 1,031,753 847,522 840,883 769,432 593,749 445,304
Total assets 1,673,393 1,494,359 1,216,462 1,054,346 786,375 550,414
Activity Ratio
Total asset turnover1 0.62 0.57 0.69 0.73 0.76 0.81
Adjusted for Deferred Taxes
Selected Financial Data (US$ in thousands)
Revenue 1,031,753 847,522 840,883 769,432 593,749 445,304
Adjusted total assets 1,662,841 1,482,979 1,173,126 976,844 715,629 515,691
Activity Ratio
Adjusted total asset turnover2 0.62 0.57 0.72 0.79 0.83 0.86

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 Total asset turnover = Revenue ÷ Total assets
= 1,031,753 ÷ 1,673,393 = 0.62

2 Adjusted total asset turnover = Revenue ÷ Adjusted total assets
= 1,031,753 ÷ 1,662,841 = 0.62


An analysis of the period from March 31, 2017, to March 31, 2022, reveals a consistent expansion of the asset base coupled with a general decline in asset utilization efficiency, followed by a slight recovery in the final year.

Asset Base Growth
Reported total assets experienced sustained growth, increasing from 550,414 thousand US$ in 2017 to 1,673,393 thousand US$ in 2022. Adjusted total assets followed a nearly identical trajectory, rising from 515,691 thousand US$ to 1,662,841 thousand US$ over the same period, indicating a significant scaling of the company's resource base.
Adjusted Total Asset Turnover Trends
A downward trend in asset efficiency is observed from 2017 through 2021. The adjusted total asset turnover ratio declined steadily from 0.86 in 2017 to a low of 0.57 in 2021. This pattern suggests that the growth in revenue did not keep pace with the rapid accumulation of assets during this timeframe. However, a reversal occurred in 2022, with the ratio improving to 0.62.
Comparison Between Reported and Adjusted Metrics
In the early years of the analysis, adjusted total asset turnover was consistently higher than reported total asset turnover, peaking at a difference of 0.05 in 2017. This indicates that certain asset adjustments initially enhanced the perceived efficiency of the asset base. By March 31, 2021, the reported and adjusted ratios converged at 0.57 and remained identical at 0.62 in 2022, suggesting that the impact of adjustments on the turnover ratio became negligible in the latter part of the period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Financial Leverage

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Total assets 1,673,393 1,494,359 1,216,462 1,054,346 786,375 550,414
Stockholders’ equity 1,503,326 1,329,675 1,065,466 936,890 689,524 452,071
Solvency Ratio
Financial leverage1 1.11 1.12 1.14 1.13 1.14 1.22
Adjusted for Deferred Taxes
Selected Financial Data (US$ in thousands)
Adjusted total assets 1,662,841 1,482,979 1,173,126 976,844 715,629 515,691
Adjusted stockholders’ equity 1,493,555 1,319,142 1,022,936 860,210 619,681 418,131
Solvency Ratio
Adjusted financial leverage2 1.11 1.12 1.15 1.14 1.15 1.23

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 Financial leverage = Total assets ÷ Stockholders’ equity
= 1,673,393 ÷ 1,503,326 = 1.11

2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted stockholders’ equity
= 1,662,841 ÷ 1,493,555 = 1.11


Between March 31, 2017, and March 31, 2022, a consistent expansion of the balance sheet is observed. Reported total assets grew from 550,414 thousand US$ to 1,673,393 thousand US$, while reported stockholders’ equity increased from 452,071 thousand US$ to 1,503,326 thousand US$. This simultaneous growth indicates a strong accumulation of capital and asset base over the six-year period.

Adjusted Financial Leverage Trend
The adjusted financial leverage ratio exhibited a general downward trajectory, starting at 1.23 in 2017 and declining to 1.11 by 2022. This trend reflects a reduction in the company's reliance on debt relative to its equity, suggesting a more conservative capital structure and an increase in financial stability over time.
Comparative Analysis of Reported and Adjusted Leverage
A high degree of correlation exists between reported and adjusted financial leverage. The variance between the two metrics was most pronounced in 2017 (1.22 reported vs. 1.23 adjusted) and converged entirely by 2022, where both metrics reached 1.11. This indicates that the adjustments made to assets and equity have a diminishing impact on the leverage ratio as the company's scale increased.
Asset and Equity Scaling
The growth in adjusted stockholders’ equity from 418,131 thousand US$ to 1,493,555 thousand US$ outperformed the growth in adjusted total assets. This disproportionate increase in equity relative to assets is the primary driver behind the observed decrease in the financial leverage ratio, signaling a strengthening of the solvency position.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Return on Equity (ROE)

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income 136,505 225,525 203,009 259,016 112,170 52,116
Stockholders’ equity 1,503,326 1,329,675 1,065,466 936,890 689,524 452,071
Profitability Ratio
ROE1 9.08% 16.96% 19.05% 27.65% 16.27% 11.53%
Adjusted for Deferred Taxes
Selected Financial Data (US$ in thousands)
Adjusted net income 138,918 254,905 235,962 251,271 154,794 77,919
Adjusted stockholders’ equity 1,493,555 1,319,142 1,022,936 860,210 619,681 418,131
Profitability Ratio
Adjusted ROE2 9.30% 19.32% 23.07% 29.21% 24.98% 18.64%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 ROE = 100 × Net income ÷ Stockholders’ equity
= 100 × 136,505 ÷ 1,503,326 = 9.08%

2 Adjusted ROE = 100 × Adjusted net income ÷ Adjusted stockholders’ equity
= 100 × 138,918 ÷ 1,493,555 = 9.30%


The financial trajectory between March 31, 2017, and March 31, 2022, is characterized by a period of rapid growth in profitability and equity, followed by a contraction in return metrics during the final fiscal year. Net income and stockholders' equity both experienced substantial increases during the first five years of the period, although the rate of return on investment showed significant volatility.

Net Income Trends
Reported net income grew aggressively from 52,116 thousand dollars in 2017 to a peak of 259,016 thousand dollars in 2019. A subsequent decline was observed in 2022, where reported net income fell to 136,505 thousand dollars. Adjusted net income followed a similar trajectory, peaking in 2021 at 254,905 thousand dollars before dropping to 138,918 thousand dollars in 2022. The variance between reported and adjusted figures was most pronounced between 2017 and 2021, suggesting the impact of non-recurring items or tax adjustments that were less influential by 2022.
Equity Growth
Stockholders' equity demonstrated consistent year-over-year growth throughout the entire period. Reported equity increased from 452,071 thousand dollars in 2017 to 1,503,326 thousand dollars in 2022. Adjusted equity mirrored this growth, rising from 418,131 thousand dollars to 1,493,555 thousand dollars. This steady accumulation of equity indicates a strong retention of earnings, although it also created a higher capital base that pressured return ratios in later years.
Return on Equity (ROE) Analysis
Both reported and adjusted ROE reached their zenith in 2019, with reported ROE at 27.65% and adjusted ROE at 29.21%. Following this peak, a downward trend is observed. Reported ROE declined from 27.65% in 2019 to 9.08% in 2022, while adjusted ROE fell from 29.21% to 9.30% over the same period. The narrowing gap between reported and adjusted ROE in 2022 suggests that the factors previously inflating the adjusted return had a diminishing effect.
Comparative Performance Insights
A significant divergence between reported and adjusted ROE existed in the early years; for instance, in 2017, the adjusted ROE was 7.11 percentage points higher than the reported ROE. By 2022, this divergence narrowed to only 0.22 percentage points. This convergence indicates a stabilization of the items requiring adjustment, while the overall decline in ROE reflects a combination of reduced net income and a significantly expanded equity base.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Adjusted Return on Assets (ROA)

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income 136,505 225,525 203,009 259,016 112,170 52,116
Total assets 1,673,393 1,494,359 1,216,462 1,054,346 786,375 550,414
Profitability Ratio
ROA1 8.16% 15.09% 16.69% 24.57% 14.26% 9.47%
Adjusted for Deferred Taxes
Selected Financial Data (US$ in thousands)
Adjusted net income 138,918 254,905 235,962 251,271 154,794 77,919
Adjusted total assets 1,662,841 1,482,979 1,173,126 976,844 715,629 515,691
Profitability Ratio
Adjusted ROA2 8.35% 17.19% 20.11% 25.72% 21.63% 15.11%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 ROA = 100 × Net income ÷ Total assets
= 100 × 136,505 ÷ 1,673,393 = 8.16%

2 Adjusted ROA = 100 × Adjusted net income ÷ Adjusted total assets
= 100 × 138,918 ÷ 1,662,841 = 8.35%


A comprehensive analysis of the financial performance from 2017 to 2022 reveals a period of rapid growth followed by a contraction in asset efficiency. While total assets grew consistently throughout the six-year period, profitability peaked in 2019, leading to a subsequent decline in the return on assets (ROA).

Asset Expansion Trends
Total assets exhibited a continuous upward trajectory. Reported total assets increased from 550,414 thousand US dollars in 2017 to 1,673,393 thousand US dollars in 2022. Adjusted total assets followed a nearly identical path, growing from 515,691 thousand US dollars to 1,662,841 thousand US dollars over the same interval. This indicates a sustained increase in the company's resource base.
Net Income Volatility
Net income demonstrated significant volatility compared to the steady growth of assets. Reported net income rose sharply from 52,116 thousand US dollars in 2017 to a peak of 259,016 thousand US dollars in 2019, before declining to 136,505 thousand US dollars by 2022. Adjusted net income showed a similar pattern, though it remained higher than reported figures in most years, peaking at 254,905 thousand US dollars in 2021 before dropping to 138,918 thousand US dollars in 2022.
Adjusted Return on Assets (ROA) Analysis
The Adjusted ROA serves as a key indicator of operational efficiency. This metric grew aggressively from 15.11% in 2017 to a peak of 25.72% in 2019. Following this peak, a downward trend emerged, with the ratio falling to 20.11% in 2020 and 17.19% in 2021, culminating in a sharp decline to 8.35% in 2022. This suggests that the growth in assets began to outpace the growth in adjusted earnings after 2019.
Comparative Analysis of Reported vs. Adjusted Metrics
A consistent variance is observed between reported and adjusted figures. Adjusted ROA remained higher than reported ROA for the majority of the period, particularly between 2017 and 2021. For instance, in 2017, the Adjusted ROA of 15.11% significantly exceeded the Reported ROA of 9.47%. However, by 2022, this gap narrowed considerably, with Reported ROA at 8.16% and Adjusted ROA at 8.35%, indicating that the factors necessitating adjustments had a diminishing impact on the overall return relative to the decline in net income.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?